Connecting epicardial adipose tissue and heart failure with preserved ejection fraction: mechanisms, management and modern perspectives.


Journal

European journal of heart failure
ISSN: 1879-0844
Titre abrégé: Eur J Heart Fail
Pays: England
ID NLM: 100887595

Informations de publication

Date de publication:
12 2022
Historique:
revised: 19 10 2022
received: 01 09 2022
accepted: 16 11 2022
pubmed: 18 11 2022
medline: 30 12 2022
entrez: 17 11 2022
Statut: ppublish

Résumé

Obesity is very common in patients with heart failure with preserved ejection fraction (HFpEF) and it has been suggested that obesity plays an important role in the pathophysiology of this disease. While body mass index defines the presence of obesity, this measure provides limited information on visceral adiposity, which is probably more relevant in the pathophysiology of HFpEF. Epicardial adipose tissue is the visceral fat situated directly adjacent to the heart and recent data demonstrate that accumulation of epicardial adipose tissue is associated with the onset, symptomatology and outcome of HFpEF. However, the mechanisms by which epicardial adipose tissue may be involved in HFpEF remain unclear. It is also questioned whether epicardial adipose tissue may be a specific target for therapy for this disease. In the present review, we describe the physiology of epicardial adipose tissue and the pathophysiological transformation of epicardial adipose tissue in response to chronic inflammatory diseases, and we postulate conceptual mechanisms on how epicardial adipose tissue may be involved in HFpEF pathophysiology. Lastly, we outline potential treatment strategies, knowledge gaps and directions for further research.

Identifiants

pubmed: 36394512
doi: 10.1002/ejhf.2741
pmc: PMC10100217
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

2238-2250

Informations de copyright

© 2022 The Authors. European Journal of Heart Failure published by John Wiley & Sons Ltd on behalf of European Society of Cardiology.

Références

J Thorac Cardiovasc Surg. 2016 Feb;151(2):e27-30
pubmed: 26414152
Sci Rep. 2022 Jan 7;12(1):147
pubmed: 34996898
Lancet. 2005 May 21-27;365(9473):1817-20
pubmed: 15910955
Eur J Heart Fail. 2018 Nov;20(11):1559-1566
pubmed: 30070041
Nutr Metab Cardiovasc Dis. 2017 Jan;27(1):41-47
pubmed: 27988072
Cardiovasc Pathol. 2004 Nov-Dec;13(6):313-6
pubmed: 15556777
Eur J Heart Fail. 2018 Sep;20(9):1269-1277
pubmed: 29963737
Clin Med Insights Cardiol. 2021 Jul 3;15:11795468211029244
pubmed: 34276231
J Am Coll Cardiol. 2017 Feb 7;69(5):556-569
pubmed: 28153111
J Am Coll Cardiol. 2020 Sep 8;76(10):1197-1211
pubmed: 32883413
Heart Fail Rev. 2022 Mar;27(2):665-675
pubmed: 34671870
Eur Heart J Cardiovasc Imaging. 2018 May 1;19(5):490-497
pubmed: 29236951
J Clin Invest. 1996 Feb 1;97(3):769-76
pubmed: 8609234
J Clin Endocrinol Metab. 2007 Mar;92(3):1023-33
pubmed: 17164304
Am Heart J. 2007 Jun;153(6):907-17
pubmed: 17540190
Eur Heart J Cardiovasc Imaging. 2019 Dec 1;20(12):1379-1387
pubmed: 31302673
Front Physiol. 2020 Jan 29;10:1607
pubmed: 32063863
Int J Cardiol. 2017 Dec 15;249:419-425
pubmed: 28986055
Eur J Heart Fail. 2022 Aug;24(8):1346-1356
pubmed: 35475591
JACC Heart Fail. 2018 Aug;6(8):640-649
pubmed: 30007558
J Clin Endocrinol Metab. 2002 Aug;87(8):3902-10
pubmed: 12161530
JACC Heart Fail. 2018 Dec;6(12):999-1007
pubmed: 30316935
J Clin Invest. 2007 Jan;117(1):175-84
pubmed: 17200717
Eur J Heart Fail. 2021 May;23(5):835-838
pubmed: 33724596
J Am Coll Cardiol. 2021 Jun 1;77(21):2638-2652
pubmed: 34045020
Gerontology. 2012;58(1):15-23
pubmed: 21135534
Circulation. 2017 Jul 4;136(1):6-19
pubmed: 28381470
Am J Cardiol. 2019 Aug 1;124(3):442-447
pubmed: 31133275
Circ Heart Fail. 2017 Apr;10(4):e003612
pubmed: 28396500
Compr Physiol. 2017 Jun 18;7(3):1051-1082
pubmed: 28640452
JACC Heart Fail. 2020 Aug;8(8):667-676
pubmed: 32653444
J Cardiovasc Magn Reson. 2010 Jul 12;12:40
pubmed: 20624277
Nat Med. 2021 Jan;27(1):58-65
pubmed: 33398160
Atherosclerosis. 2019 May;284:230-236
pubmed: 30777338
J Korean Med Sci. 2022 Mar 07;37(9):e55
pubmed: 35257523
Mol Ther Methods Clin Dev. 2020 Dec 25;20:409-422
pubmed: 33575433
Physiol Rev. 2013 Jan;93(1):1-21
pubmed: 23303904
Clin Cardiol. 2021 Jul;44(7):987-993
pubmed: 34085724
J Am Coll Cardiol. 2011 Apr 26;57(17):1745-51
pubmed: 21511110
Circ Heart Fail. 2022 Mar;15(3):e009238
pubmed: 34935412
Ann Thorac Surg. 2017 May;103(5):1622-1630
pubmed: 28223054
ESC Heart Fail. 2022 Apr;9(2):953-957
pubmed: 35146949
Eur J Heart Fail. 2022 Dec;24(12):2251-2260
pubmed: 36196462
Eur J Heart Fail. 2021 Nov;23(11):1858-1871
pubmed: 34427016
ESC Heart Fail. 2021 Aug;8(4):2535-2545
pubmed: 33939300
Cardiovasc Res. 2000 Jan 14;45(2):279-93
pubmed: 10728348
Eur J Nucl Med Mol Imaging. 2015 Sep;42(10):1562-73
pubmed: 26054890
Anat Rec A Discov Mol Cell Evol Biol. 2003 Mar;271(1):249-58
pubmed: 12552641
Circ Heart Fail. 2021 Feb;14(2):e007530
pubmed: 33478242
Eur J Heart Fail. 2020 Sep;22(9):1540-1550
pubmed: 32619081
Int J Cardiol. 2014 Oct 20;176(3):611-7
pubmed: 25156856
J Am Coll Cardiol. 2017 Dec 5;70(22):2739-2749
pubmed: 29191321
Int J Obes. 1990 Dec;14(12):1013-22
pubmed: 2086494
Cell Metab. 2015 Jan 6;21(1):33-8
pubmed: 25565203
Clin Med Insights Cardiol. 2013;7:43-50
pubmed: 23471126
Obes Res. 2003 Feb;11(2):304-10
pubmed: 12582228
Circ Cardiovasc Imaging. 2018 Aug;11(8):e007372
pubmed: 30354491
JACC Heart Fail. 2020 Aug;8(8):657-666
pubmed: 32653449
J Am Coll Cardiol. 2021 Oct 26;78(17):1730-1745
pubmed: 34674819
Circulation. 2011 Jul 5;124(1):67-76
pubmed: 21670228
Circ Heart Fail. 2011 May;4(3):324-31
pubmed: 21350053
Eur J Nucl Med Mol Imaging. 2020 Jul;47(7):1746-1756
pubmed: 31897585
J Anat. 1972 May;112(Pt 1):35-9
pubmed: 5086212
Diabetes. 2009 Mar;58(3):718-25
pubmed: 19074987
Int J Cardiol. 2022 Jun 15;357:140-145
pubmed: 35395282
Circulation. 2003 Nov 18;108(20):2460-6
pubmed: 14581396
Int J Cardiol. 2022 Sep 1;362:118-125
pubmed: 35662556
Obes Rev. 2021 Jan;22(1):e13136
pubmed: 32896056
Eur J Heart Fail. 2022 Jan;24(1):4-131
pubmed: 35083827
J Am Coll Cardiol. 2013 Jul 23;62(4):263-71
pubmed: 23684677
Eur J Heart Fail. 2020 Sep;22(9):1551-1567
pubmed: 32441863
J Clin Endocrinol Metab. 2009 Sep;94(9):3611-5
pubmed: 19567523
Eur J Heart Fail. 2020 Mar;22(3):445-454
pubmed: 31696627
J Am Heart Assoc. 2021 Jul 20;10(14):e020920
pubmed: 34238024

Auteurs

Gijs van Woerden (G)

Department of Cardiology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.

Dirk J van Veldhuisen (DJ)

Department of Cardiology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.

B Daan Westenbrink (BD)

Department of Cardiology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.

Rudolf A de Boer (RA)

Department of Cardiology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.

Michiel Rienstra (M)

Department of Cardiology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.

Thomas M Gorter (TM)

Department of Cardiology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH